These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 12719697)

  • 1. Biochemical diagnosis of gastroenteropancreatic endocrine tumors.
    Tartaglia A; Bianchini S; Vezzadini P
    Minerva Med; 2003 Feb; 94(1):1-7. PubMed ID: 12719697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of calcium provocative test in the diagnosis of gastroenteropancreatic endocrine tumors.
    Vezzadini C; Poggioli R; Casoni I; Vezzadini P
    Panminerva Med; 1996 Dec; 38(4):255-8. PubMed ID: 9063035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular genetics of gastroenteropancreatic neuroendocrine tumors.
    Toumpanakis CG; Caplin ME
    Am J Gastroenterol; 2008 Mar; 103(3):729-32. PubMed ID: 18341492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues.
    Nikou GC; Lygidakis NJ; Toubanakis C; Pavlatos S; Tseleni-Balafouta S; Giannatou E; Mallas E; Safioleas M
    Hepatogastroenterology; 2005; 52(63):731-41. PubMed ID: 15966194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical relevance of chromogranin A as a biomarker for gastroenteropancreatic neuroendocrine tumors.
    Lawrence B; Gustafsson BI; Kidd M; Pavel M; Svejda B; Modlin IM
    Endocrinol Metab Clin North Am; 2011 Mar; 40(1):111-34, viii. PubMed ID: 21349414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical diagnosis of neuroendocrine GEP tumor.
    Oberg K
    Yale J Biol Med; 1997; 70(5-6):501-8. PubMed ID: 9825477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The gastroenteropancreatic endocrine system and related tumors.
    Solcia E; Capella C; Fiocca R; Cornaggia M; Bosi F
    Gastroenterol Clin North Am; 1989 Dec; 18(4):671-93. PubMed ID: 2575601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neuroendocrine tumors of the gastrointestinal tract. 1: Clinical aspects].
    Müller MK; Niederle N; Singer MV
    Fortschr Med; 1992 Jan; 110(3):50, 53-4. PubMed ID: 1607137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Endoscopic diagnosis of gastroenteropancreatic neuroendocrine tumors].
    López-Jamar JM
    Endocrinol Nutr; 2009 Sep; 56 Suppl 3():8-13. PubMed ID: 20542214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 7B2, a possible marker for nonfunctioning pancreatic islet cell tumor.
    Iguchi H; Yasuda D; Yamada Y; Funakoshi A; Wakasugi H; Bloom SR; Chretien M
    Horm Metab Res; 1991 Oct; 23(10):486-9. PubMed ID: 1662184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropilin-2 is a novel marker expressed in pancreatic islet cells and endocrine pancreatic tumours.
    Cohen T; Herzog Y; Brodzky A; Greenson JK; Eldar S; Gluzman-Poltorak Z; Neufeld G; Resnick MB
    J Pathol; 2002 Sep; 198(1):77-82. PubMed ID: 12210066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The utility of circulating levels of human pancreatic polypeptide as a marker for islet cell tumors.
    Langstein HN; Norton JA; Chiang V; O'Dorisio TM; Maton PN; Marx SJ; Jensen RT
    Surgery; 1990 Dec; 108(6):1109-15; discussion 1115-6. PubMed ID: 2174193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromogranin A: a sensitive biomarker for the detection and post-treatment monitoring of gastroenteropancreatic neuroendocrine tumors.
    Singh S; Law C
    Expert Rev Gastroenterol Hepatol; 2012 Jun; 6(3):313-34. PubMed ID: 22646254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastrinomas associated with MEN-1 syndrome: new insights for the diagnosis and management in a series of 11 patients.
    Nikou GC; Toubanakis C; Nikolaou P; Giannatou E; Marinou K; Safioleas M; Karamanolis D
    Hepatogastroenterology; 2005; 52(66):1668-76. PubMed ID: 16334754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secretion of pancreatic polypeptide in patients with pancreatic endocrine tumors.
    Adrian TE; Uttenthal LO; Williams SJ; Bloom SR
    N Engl J Med; 1986 Jul; 315(5):287-91. PubMed ID: 3014338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum markers for pancreatic islet cell and intestinal carcinoid tumors: a comparison of neuron-specific enolase, beta-human chorionic gonadotropin and pancreatic polypeptide.
    Prinz RA; Bermes EW; Kimmel JR; Marangos PJ
    Surgery; 1983 Dec; 94(6):1019-23. PubMed ID: 6196846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastroenteropancreatic endocrine tumors: clinical characterization before therapy.
    Baudin E
    Nat Clin Pract Endocrinol Metab; 2007 Mar; 3(3):228-39. PubMed ID: 17315031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New perspectives in diagnosis and therapy of endocrine gastroenteropancreatic (GEP) tumors with somatostatin analogues].
    Rubello D; Rufini V; De Carlo E; Martini C; Calcagni ML; Sicolo N; Troncone L; Casara D
    Minerva Endocrinol; 2003 Dec; 28(4):259-96. PubMed ID: 14752399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Approach to hepatic involvement by endocrine tumors of the gastrointestinal tract.
    Stockmann F; Creutzfeldt W
    Semin Liver Dis; 1988 Aug; 8(3):254-62. PubMed ID: 2906761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pancreatic endocrine tumors].
    Târcoveanu E; Moldovanu R; Georgescu S; Niculescu D; Lupaşcu C; Dimofte G
    Chirurgia (Bucur); 2006; 101(2):175-81. PubMed ID: 16752684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.